RT Journal Article SR Electronic T1 The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.08.21.20179358 DO 10.1101/2020.08.21.20179358 A1 Jia Liu A1 Xuecheng Yang A1 Hua Wang A1 Ziwei Li A1 Hui Deng A1 Jing Liu A1 Shue Xiong A1 Junyi He A1 Chunxia Guo A1 Weixian Wang A1 Gennadiy Zelinskyy A1 Mirko Trilling A1 Ulf Dittmer A1 Mengji Lu A1 Kathrin Sutter A1 Tina Senff A1 Christopher Menne A1 Joerg Timm A1 Yanfang Zhang A1 Fei Deng A1 Xuemei Feng A1 Yinping Lu A1 Jun Wu A1 Dongliang Yang A1 Baoju Wang A1 Xin Zheng YR 2020 UL http://medrxiv.org/content/early/2020/08/25/2020.08.21.20179358.abstract AB The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects millions of people and killed hundred-thousands of individuals. While acute and intermediate interactions between SARS-CoV-2 and the immune system have been studied extensively, long-term impacts on the cellular immune system remained to be analyzed. Here, we comprehensively characterized immunological changes in peripheral blood mononuclear cells in 49 COVID-19 convalescent individuals (CI) in comparison to 27 matched SARS-CoV-2 unexposed individuals (UI). Despite recovery from the disease for more than 2 months, CI showed significant decreases in frequencies of invariant NKT and NKT-like cells compared to UI. Concomitant with the decrease in NKT-like cells, an increase in the percentage of Annexin V and 7-AAD double positive NKT-like cells was detected, suggesting that the reduction in NKT-like cells results from cell death months after recovery. Significant increases in regulatory T cell frequencies, TIM-3 expression on CD4 and CD8 T cells, as well as PD-L1 expression on B cells were also observed in CI, while the cytotoxic potential of T cells and NKT-like cells, defined by GzmB expression, was significantly diminished. However, both CD4 and CD8 T cells of CI showed increased Ki67 expression and were fully capable to proliferate and produce effector cytokines upon TCR stimulation. Collectively, we provide the first comprehensive characterization of immune signatures in patients recovering from SARS-CoV-2 infection, suggesting that the cellular immune system of COVID-19 patients is still under a sustained influence even months after the recovery from disease.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThere is no clinical trial in the present studyFunding StatementThis work is supported by the Fundamental Research Funds for the Central Universities (2020kfyXGYJ028, 2020kfyXGYJ046 and 2020kfyXGYJ016), the National Natural Science Foundation of China (81861138044 and 91742114), the National Science and Technology Major Project (2017ZX10202203), and the Medical Faculty of the University of Duisburg-Essen and Stiftung Universitaetsmedizin, University Hospital Essen, Germany.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe availability of all data referred to in the manuscript must obtain permission from the corresponding author.